$4.20
0.00% yesterday
NYSE, Nov 28, 07:24 pm CET
ISIN
US30050B1017
Symbol
EVH

Evolent Health Inc Class A Stock price

$4.20
-3.44 45.03% 1M
-3.01 41.75% 6M
-7.05 62.67% YTD
-9.06 68.33% 1Y
-22.71 84.39% 3Y
-10.37 71.17% 5Y
-12.25 74.47% 10Y
-14.66 77.73% 20Y
NYSE, Closing price Wed, Nov 26 2025
-0.11 2.55%
ISIN
US30050B1017
Symbol
EVH

Key metrics

Basic
Market capitalization
$468.7m
Enterprise Value
$1.4b
Net debt
$943.3m
Cash
$116.7m
Shares outstanding
111.6m
Valuation (TTM | estimate)
P/E
negative | 16.9
P/S
0.2 | 0.2
EV/Sales
0.7 | 0.7
EV/FCF
negative
P/B
0.6
Financial Health
Equity Ratio
46.8%
Return on Equity
-7.8%
ROCE
0.9%
ROIC
0.9%
Debt/Equity
1.3
Financials (TTM | estimate)
Revenue
$2.1b | $1.9b
EBITDA
$117.7m | $153.3m
EBIT
$17.6m | $99.7m
Net Income
$-180.9m | $27.7m
Free Cash Flow
$-68.7m
Growth (TTM | estimate)
Revenue
-16.7% | -25.5%
EBITDA
13.3% | 32.4%
EBIT
218.1% | 3,962.9%
Net Income
-73.5% | 129.7%
Free Cash Flow
-162.7%
Margin (TTM | estimate)
Gross
18.4%
EBITDA
5.7% | 8.1%
EBIT
0.9%
Net
-8.8% | 1.5%
Free Cash Flow
-3.3%
More
EPS
$-1.6
FCF per Share
$-0.6
Short interest
17.0%
Employees
5k
Rev per Employee
$570.0k
Show more

Is Evolent Health Inc Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,070 stocks worldwide.

Evolent Health Inc Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

18 Analysts have issued a Evolent Health Inc Class A forecast:

16x Buy
89%
2x Hold
11%

Analyst Opinions

18 Analysts have issued a Evolent Health Inc Class A forecast:

Buy
89%
Hold
11%

Financial data from Evolent Health Inc Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
2,054 2,054
17% 17%
100%
- Direct Costs 1,676 1,676
19% 19%
82%
378 378
4% 4%
18%
- Selling and Administrative Expenses 263 263
4% 4%
13%
- Research and Development Expense - -
-
-
118 118
13% 13%
6%
- Depreciation and Amortization 100 100
16% 16%
5%
EBIT (Operating Income) EBIT 18 18
218% 218%
1%
Net Profit -181 -181
74% 74%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Evolent Health Inc Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evolent Health Inc Class A Stock News

Neutral
Seeking Alpha
17 days ago
Evolent Health, Inc. ( EVH ) UBS Global Healthcare Conference 2025 November 11, 2025 5:00 PM EST Company Participants John Johnson - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Presentation Kevin Caliendo UBS Investment Bank, Research Division Good afternoon. This is Kevin Caliendo, health care service and distribution and IT anal...
Neutral
Seeking Alpha
21 days ago
Evolent Health, Inc. ( EVH ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Seth Blackley - Co-Founder, CEO & Director John Johnson - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Investment Bank, Research Division Daniel Grosslight - Citigroup Inc., Research Division John Stansel - JPMorgan Chase & Co, Research Division Lucas Romanski - TD C...
Neutral
PRNewsWire
22 days ago
WASHINGTON , Nov. 6, 2025 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation's fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care — all without relying on prior auth...
More Evolent Health Inc Class A News

Company Profile

Evolent Health, Inc. engages in the provision of health care delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. It operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Head office United States
CEO Seth Blackley
Employees 4,500
Founded 2011
Website www.evolent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today